financetom
Business
financetom
/
Business
/
Singapore's Grab raises annual revenue forecast, shares jump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Singapore's Grab raises annual revenue forecast, shares jump
Nov 11, 2024 5:55 PM

(Reuters) -Singapore's Grab Holdings raised its forecast for fiscal 2024 revenue on Monday, as the Southeast Asian tech firm anticipates robust growth in its food delivery and ride-hailing businesses during the busy holiday season.

U.S.-listed shares of the company jumped more than 10% in extended trading.

Grab's mainstay food delivery business has been recovering from a post-pandemic slump in demand as consumers increase their discretionary spending budgets in a sign of economic easing.

"We remain bullish on the long-term growth outlook of Southeast Asia, and are firing on all cylinders to capture the strong user demand trends," Grab CEO Anthony Tan said.

The company expects revenue in the range of $2.76 billion to $2.78 billion, compared with its prior projection of between $2.70 billion and $2.75 billion.

Grab has been attempting to introduce cheaper options for its ride-hailing services to woo price-wary customers. On the other hand, the firm has been trying to promote its premium offerings as well to boost its earnings.

The margins for the more premium rides are 1.2 times higher than the standard rides offered by the company, CFO Peter Oey told Reuters.

Grab reported third-quarter revenue of $716 million, exceeding Visible Alpha estimates of $700.8 million.

Oey said transactions made by customers were up 22% in the third quarter and subscribers of the company's services spend four times that of non-subscribers.

The firm also raised its annual core profit forecast to between $308 million and $313 million, from $250 million and $270 million.

Revenue in the deliveries segment increased 16% to $380 million, surpassing estimates of $374.2 million.

The company left its annual adjusted free cash flow forecast unchanged and beat estimates in its financial segment.

On an adjusted basis, the company earned 1 cent per share, compared with estimates of a break-even quarter, as per data compiled by LSEG.

(Reporting by Zaheer Kachwala in Bengaluru; Editing by Maju Samuel and Subhranshu Sahu)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Finance guide could spur extra $200 billion for sustainable development, JPMorgan says
Finance guide could spur extra $200 billion for sustainable development, JPMorgan says
Oct 23, 2024
* Impact disclosure guidance released by Taskforce * Group chaired by JPMorgan ( JPM ), Natixis * Aims to help countries, companies raise impact finance By Karin Strohecker and Simon Jessop WASHINGTON, Oct 23 (Reuters) - A new guide for countries and companies seeking financing for activities that have a positive and verifiable social or environmental impact could unlock an...
Synaptics Expands Taiwan Presence, Operations
Synaptics Expands Taiwan Presence, Operations
Oct 23, 2024
03:57 AM EDT, 10/23/2024 (MT Newswires) -- Synaptics ( SYNA ) said late Tuesday it has expanded in the Taiwanese city of Hsinchu, making Taiwan the company's largest base of personnel worldwide. The company said the expansion gives it headroom to grow both its essential operations and engineering expertise. The facilities will house the team developing its AI-enabled devices for...
--Mueller Water Products Increases Quarterly Dividend to $0.067 per Share From $0.064; Payable Nov. 20 to Shareholders of Record on Nov. 8
--Mueller Water Products Increases Quarterly Dividend to $0.067 per Share From $0.064; Payable Nov. 20 to Shareholders of Record on Nov. 8
Oct 23, 2024
04:03 AM EDT, 10/23/2024 (MT Newswires) -- Price: 22.01, Change: -0.06, Percent Change: -0.27 ...
Alto Neuroscience Says Phase 2b Study in Major Depressive Disorder Fails to Meet Primary Endpoint
Alto Neuroscience Says Phase 2b Study in Major Depressive Disorder Fails to Meet Primary Endpoint
Oct 23, 2024
04:06 AM EDT, 10/23/2024 (MT Newswires) -- Alto Neuroscience ( ANRO ) said late Tuesday a phase 2b study of ALTO-100 in patients with major depressive disorder failed to meet its primary endpoint compared with placebo. Treatment with ALTO-100 did not demonstrate improvement in depressive symptoms compared to placebo in patients with a memory-based cognitive biomarker, Alto Neuroscience ( ANRO...
Copyright 2023-2025 - www.financetom.com All Rights Reserved